Quick Answer
RESMED INC reported Stockholders Equity of $5.97 billion for fiscal year 2025.
RESMED INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.97B | +22.7% |
| 2024 | $4.86B | +17.8% |
| 2023 | $4.13B | +22.9% |
| 2022 | $3.36B | +16.5% |
| 2021 | $2.89B | +15.6% |
| 2020 | $2.50B | +20.5% |
| 2019 | $2.07B | +0.6% |
| 2018 | $2.06B | +5.0% |
| 2017 | $1.96B | +15.7% |
| 2016 | $1.69B | +6.8% |
| 2015 | $1.59B | -9.7% |
| 2014 | $1.76B | +9.2% |
| 2013 | $1.61B | +0.2% |
| 2012 | $1.61B | -7.1% |
| 2011 | $1.73B | +34.4% |
| 2010 | $1.29B | +15.5% |
| 2009 | $1.12B | +3.1% |
| 2008 | $1.08B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $6.32B | +20.3% | +3.3% |
| September 30, 2025 | $6.12B | +17.8% | +2.6% |
| June 30, 2025 | $5.97B | +22.7% | +7.6% |
| March 31, 2025 | $5.55B | +19.8% | +5.6% |
| December 31, 2024 | $5.25B | +17.2% | +1.1% |
| September 30, 2024 | $5.20B | +22.2% | +6.8% |
| June 30, 2024 | $4.86B | +17.8% | +5.1% |
| March 31, 2024 | $4.63B | +17.7% | +3.3% |
- RESMED INC showed an increase of +22.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, RESMED INC’s stockholders equity has grown by 451.7% (from $1.08 billion to $5.97 billion).
- The most recent figure is from RESMED INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: